William Blair & Company
FXH icon

William Blair & Company’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

William Blair & Company’s Portfolio FXH Stock Details FXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.1K Hold
165
– – ﹤0.01% 1785
2025
Q4 		$18.8K Hold
165
– – ﹤0.01% 1731
2025
Q3 		$18.1K Hold
165
– – ﹤0.01% 1725
2025
Q2 		$17.1K Hold
165
– – ﹤0.01% 1690
2025
Q1 		$17.1K Sell
165
-500
-75% -$53.5K ﹤0.01% 1672
2024
Q4 		$69.2K Sell
665
-24
-3% -$2.61K ﹤0.01% 1567
2024
Q3 		$77.1K Hold
689
– – ﹤0.01% 1572
2024
Q2 		$72K Hold
689
– – ﹤0.01% 1554
2024
Q1 		$75.5K Buy
689
+500
+265% +$52.8K ﹤0.01% 1548
2023
Q4 		$19.6K Sell
189
-20,910
-99% -$2.02M ﹤0.01% 1667
2023
Q3 		$2.05M Sell
21,099
-518
-2% -$53.8K 0.01% 649
2023
Q2 		$2.34M Buy
21,617
+418
+2% +$44.8K 0.01% 629
2023
Q1 		$2.28M Buy
21,199
+153
+0.7% +$16.6K 0.01% 624
2022
Q4 		$2.29M Sell
21,046
-53
-0.3% -$5.56K 0.01% 598
2022
Q3 		$2.05M Buy
21,099
+43
+0.2% +$4.53K 0.01% 616
2022
Q2 		$2.17M Buy
21,056
+561
+3% +$60.4K 0.01% 616
2022
Q1 		$2.35M Sell
20,495
-220
-1% -$24.7K 0.01% 661
2021
Q4 		$2.57M Buy
20,715
+311
+2% +$37.2K 0.01% 651
2021
Q3 		$2.43M Buy
20,404
+111
+0.5% +$13.6K 0.01% 654
2021
Q2 		$2.38M Sell
20,293
-166
-0.8% -$18.9K 0.01% 657
2021
Q1 		$2.22M Buy
20,459
+594
+3% +$65K 0.01% 661
2020
Q4 		$2.14M Buy
19,865
+284
+1% +$28.9K 0.01% 627
2020
Q3 		$1.85M Buy
19,581
+5,734
+41% +$537K 0.01% 601
2020
Q2 		$1.25M Buy
13,847
+10,041
+264% +$861K 0.01% 673
2020
Q1 		$282K Sell
3,806
-270
-7% -$21.9K ﹤0.01% 1033
2019
Q4 		$343K Hold
4,076
– – ﹤0.01% 1130
2019
Q3 		$302K Sell
4,076
-40
-1% -$3.05K ﹤0.01% 1114
2019
Q2 		$319K Buy
4,116
+800
+24% +$59.5K ﹤0.01% 1135
2019
Q1 		$253K Hold
3,316
– – ﹤0.01% 1215
2018
Q4 		$245K Buy
3,316
+1,240
+60% +$93.9K ﹤0.01% 1163
2018
Q3 		$176K Sell
2,076
-153
-7% -$12.2K ﹤0.01% 1308
2018
Q2 		$165K Sell
2,229
-766
-26% -$55.4K ﹤0.01% 1291
2018
Q1 		$208K Buy
+2,995
New +$216K ﹤0.01% 1195

Other funds holding FXH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RW
Rockport Wealth Fairview Park, Ohio $595M AUM 23.65% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PFA
Perryman Financial Advisory Dallas, Texas $751M AUM

William Blair & Company's FXH Position: Q1 2026 in Review

William Blair & Company held its First Trust Health Care AlphaDEX Fund (FXH) position steady in Q1 2026 at 165 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1785.

William Blair & Company first reported a position in FXH in Q1 2018 and has held it in 33 quarters since. The position peaked at $2.57M in Q4 2021. 238 funds tracked by Wall St. Rank hold FXH as of Q1 2026.

  • William Blair & Company held 165 shares of First Trust Health Care AlphaDEX Fund worth $18.1K as of Q1 2026.
  • William Blair & Company left its First Trust Health Care AlphaDEX Fund share count unchanged in Q1 2026.
  • First Trust Health Care AlphaDEX Fund made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #1785 holding.
  • William Blair & Company first reported a position in First Trust Health Care AlphaDEX Fund in Q1 2018 and has held it in 33 quarters since.
  • William Blair & Company's First Trust Health Care AlphaDEX Fund position peaked at $2.57M in Q4 2021.
  • 238 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.